OTLK Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.80%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Oncobiologics Insider Trading History Chart

Oncobiologics Share Price & Price History

^$2.06

▲ +0.09 (4.57%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Oncobiologics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/26/2024	Lawrence A Kenyon	CFO	Buy	5,000	$5.69	$28,450.00	5,946
3/28/2024	Yezan Munther Haddadin	Director	Buy	1,882	$11.82	$22,245.24	5,049
4/20/2023	Terry Dagnon	Insider	Sell	26,000	$22.80	$592,800.00	32,652
1/19/2023	Jeff Evanson	Insider	Sell	5,162	$24.40	$125,952.80	50,648
1/17/2023	Jeff Evanson	Insider	Sell	1,358	$26.20	$35,579.60	57,498

SEC Filings (Institutional Ownership Changes) for Oncobiologics (NASDAQ:OTLK)

11.20% of Oncobiologics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Oncobiologics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/13/2025	Russell Investments Group Ltd.	24,477	$39K	0.0%	+865.2%	0.073%
5/16/2025	Goldman Sachs Group Inc.	103,524	$0.13M	0.0%	+74.1%	0.323%
5/16/2025	AQR Capital Management LLC	84,671	$0.10M	0.0%	+42.7%	0.264%
2/17/2025	Tang Capital Management LLC	182,502	$0.35M	0.0%	-88.3%	0.571%
2/14/2025	Jane Street Group LLC	26,218	$50K	0.0%	+133.9%	0.082%
2/14/2025	Northern Trust Corp	111,750	$0.21M	0.0%	-6.0%	0.349%
2/13/2025	Scotia Capital Inc.	73,989	$0.14M	0.0%	+124.4%	0.231%
2/13/2025	Renaissance Technologies LLC	130,374	$0.25M	0.0%	N/A	0.408%
2/13/2025	Russell Investments Group Ltd.	17,168	$32K	0.0%	+34,936.7%	0.054%
2/10/2025	Commonwealth Equity Services LLC	25,615	$48K	0.0%	N/A	0.080%
2/6/2025	Charles Schwab Investment Management Inc.	36,048	$68K	0.0%	-29.9%	0.113%
2/4/2025	Bank of New York Mellon Corp	29,764	$56K	0.0%	+44.8%	0.093%
1/30/2025	Rhumbline Advisers	188,050	$0.36M	0.0%	+1,329.6%	0.588%
11/19/2024	Barclays PLC	20,943	$0.11M	0.0%	+677.4%	0.089%
11/16/2024	Geode Capital Management LLC	341,959	$1.83M	0.0%	+49.2%	1.445%
11/15/2024	Barclays PLC	20,943	$0.11M	0.0%	+677.4%	0.089%
11/15/2024	XTX Topco Ltd	37,328	$0.20M	0.0%	N/A	0.158%
11/15/2024	Sphera Funds Management LTD.	413,545	$2.21M	0.4%	-27.6%	1.748%
11/15/2024	State Street Corp	232,542	$1.24M	0.0%	+10.0%	0.983%
11/14/2024	Caligan Partners LP	318,699	$1.70M	0.5%	-36.3%	1.347%
11/13/2024	Great Point Partners LLC	1,293,028	$6.91M	2.0%	-24.0%	5.465%
11/12/2024	Charles Schwab Investment Management Inc.	51,459	$0.28M	0.0%	+55.1%	0.217%
10/22/2024	Christensen King & Associates Investment Services Inc.	10,276	$55K	0.0%	N/A	0.044%
8/15/2024	Susquehanna Fundamental Investments LLC	41,020	$0.30M	0.0%	N/A	0.175%
8/15/2024	AQR Capital Management LLC	10,164	$75K	0.0%	N/A	0.043%
8/14/2024	Squarepoint Ops LLC	31,388	$0.23M	0.0%	N/A	0.134%
8/14/2024	Great Point Partners LLC	1,701,510	$12.56M	2.4%	+15.0%	7.270%
7/16/2024	LVW Advisors LLC	47,730	$0.35M	0.1%	N/A	0.204%
7/12/2024	Rosalind Advisors Inc.	450,000	$3.32M	2.4%	+44.3%	1.922%
5/20/2024	Virtu Financial LLC	18,213	$0.22M	0.0%	-73.3%	0.140%
5/14/2024	American International Group Inc.	3,873	$46K	0.0%	-95.0%	0.030%
5/10/2024	Vanguard Group Inc.	341,300	$4.08M	0.0%	-94.8%	2.623%
5/1/2024	BNP Paribas Financial Markets	4,505	$54K	0.0%	-94.8%	0.035%
4/25/2024	Rosalind Advisors Inc.	311,775	$3.72M	3.5%	N/A	2.396%
2/12/2024	Scotia Capital Inc.	284,080	$0.11M	0.0%	-16.1%	0.109%
11/15/2023	Scotia Capital Inc.	338,439	$75K	0.0%	+420.9%	0.130%
11/3/2023	Gables Capital Management Inc.	154,500	$34K	0.0%	+132.3%	0.059%
10/24/2023	Bank of New York Mellon Corp	434,567	$96K	0.0%	-8.3%	0.167%
9/21/2023	Barclays PLC	30,963	$54K	0.0%	-60.9%	0.012%
8/7/2023	Lincoln National Corp	320,300	$0.56M	0.0%	+64.8%	0.125%
8/4/2023	Main Street Financial Solutions LLC	25,000	$44K	0.0%	N/A	0.010%
8/3/2023	Scotia Capital Inc.	64,976	$0.11M	0.0%	N/A	0.025%
7/18/2023	Stratos Wealth Advisors LLC	17,000	$30K	0.0%	N/A	0.007%
4/28/2023	SG Americas Securities LLC	61,941	$68K	0.0%	N/A	0.024%
2/13/2023	GSA Capital Partners LLP	277,785	$0.30M	0.0%	+65.5%	0.108%
2/10/2023	Vista Finance LLC	277,615	$0.30M	0.4%	-30.2%	0.108%
2/8/2023	Lincoln National Corp	194,300	$0.21M	0.0%	+26.7%	0.076%
2/7/2023	Metis Global Partners LLC	48,289	$52K	0.0%	+174.3%	0.019%
1/17/2023	PPS&V Asset Management Consultants Inc.	50,153	$54K	0.1%	N/A	0.022%
11/14/2022	Vista Finance LLC	397,555	$0.49M	0.6%	-61.0%	0.176%
8/5/2022	Vista Finance LLC	1,020,370	$1.04M	1.4%	+3.7%	0.452%
8/2/2022	Lincoln National Corp	153,300	$0.16M	0.0%	+48.4%	0.068%
8/1/2022	Graypoint LLC	37,500	$38K	0.0%	-25.0%	0.017%
7/26/2022	First Merchants Corp	149,170	$0.15M	0.0%	+45.1%	0.066%
7/22/2022	LVW Advisors LLC	1,733,633	$1.77M	0.4%	-0.6%	0.767%
7/18/2022	Gables Capital Management Inc.	61,500	$63K	0.0%	+32.3%	0.027%
7/12/2022	Flower City Capital	51,778	$53K	0.1%	+158.9%	0.023%
5/11/2022	GSA Capital Partners LLP	256,200	$0.46M	0.1%	+22.0%	0.114%
5/2/2022	Gables Capital Management Inc.	46,500	$83K	0.1%	+1,228.6%	0.021%
4/26/2022	Vista Finance LLC	983,645	$1.75M	2.6%	N/A	0.439%
4/26/2022	First Merchants Corp	102,770	$0.18M	0.0%	+201.9%	0.046%
4/19/2022	Graypoint LLC	50,000	$89K	0.0%	N/A	0.022%
4/14/2022	Flower City Capital	20,000	$36K	0.0%	N/A	0.009%
2/14/2022	GSA Capital Partners LLP	210,042	$0.29M	0.0%	N/A	0.094%
2/10/2022	Alamar Capital Management LLC	20,000	$27K	0.0%	N/A	0.009%
2/9/2022	Principal Financial Group Inc.	36,686	$50K	0.0%	+92.8%	0.016%
2/8/2022	ProShare Advisors LLC	19,461	$26K	0.0%	+70.5%	0.009%
2/8/2022	Northern Trust Corp	817,545	$1.11M	0.0%	-2.1%	0.365%
2/7/2022	SG Americas Securities LLC	25,235	$34K	0.0%	-43.7%	0.011%
2/4/2022	Envestnet Asset Management Inc.	36,461	$50K	0.0%	N/A	0.016%
2/4/2022	IndexIQ Advisors LLC	187,692	$0.26M	0.0%	-6.1%	0.084%
2/2/2022	KWB Wealth	27,284	$37K	0.0%	N/A	0.012%
2/2/2022	Oppenheimer & Co. Inc.	22,100	$30K	0.0%	+71.3%	0.010%
1/27/2022	First Merchants Corp	34,044	$46K	0.0%	N/A	0.015%
1/26/2022	Lincoln National Corp	103,300	$0.14M	0.0%	-59.2%	0.046%
11/16/2021	Stelac Advisory Services LLC	390,000	$0.85M	0.2%	+39.3%	0.222%
11/16/2021	Two Sigma Advisers LP	309,900	$0.67M	0.0%	-55.5%	0.177%
11/16/2021	Two Sigma Investments LP	271,534	$0.59M	0.0%	-69.5%	0.155%
11/15/2021	AXA S.A.	145,013	$0.32M	0.0%	-53.6%	0.083%
11/12/2021	Renaissance Technologies LLC	254,781	$0.55M	0.0%	N/A	0.145%
11/12/2021	Geode Capital Management LLC	1,552,438	$3.37M	0.0%	+2.4%	0.885%
11/10/2021	Goldman Sachs Group Inc.	151,110	$0.33M	0.0%	+1,327.6%	0.086%
11/10/2021	IndexIQ Advisors LLC	199,822	$0.43M	0.0%	+11.1%	0.114%
11/10/2021	Citigroup Inc.	11,445	$25K	0.0%	+174.5%	0.007%
11/9/2021	Barclays PLC	36,396	$79K	0.0%	+113.8%	0.021%
11/9/2021	BlackRock Inc.	5,838,612	$12.67M	0.0%	+1.5%	3.330%
11/9/2021	Principal Financial Group Inc.	19,025	$41K	0.0%	+35.9%	0.011%
11/5/2021	Advisor Group Holdings Inc.	30,246	$66K	0.0%	-52.6%	0.017%
11/2/2021	New York State Common Retirement Fund	35,884	$78K	0.0%	-52.2%	0.020%
11/1/2021	SG Americas Securities LLC	44,828	$97K	0.0%	N/A	0.026%
10/29/2021	Commonwealth Equity Services LLC	21,522	$46K	0.0%	N/A	0.012%
10/28/2021	Endurance Wealth Management Inc.	15,000	$33K	0.0%	N/A	0.009%
10/22/2021	Strs Ohio	27,000	$58K	0.0%	+33.0%	0.015%

Data available starting January 2016

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and license agreements with BioLexis Pte. Ltd. and Zhejiang Huahai Pharmaceutical Co., Ltd. The company was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey.

Today's Range

Now: $2.06

$1.93

$2.10

50 Day Range

MA: $1.42

$0.97

$2.06

52 Week Range

Now: $2.06

$0.79

$3.39

Volume

2,347,298 shs

Average Volume

5,303,301 shs

Market Capitalization

$91.51 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.17

Who are the company insiders with the largest holdings of Oncobiologics?: Oncobiologics' top insider shareholders include:
Lawrence A Kenyon (CFO)
Yezan Munther Haddadin (Director)
Learn More about top insider investors at Oncobiologics.
Who are the major institutional investors of Oncobiologics?: Oncobiologics' top institutional investors include:
Citadel Advisors LLC — 0.00%
Susquehanna International Group LLP — 0.00%
Group One Trading LLC — 0.00%
Learn More about top institutional investors of Oncobiologics stock.
Which major investors are selling Oncobiologics stock?: During the last quarter, OTLK stock was sold by these institutional investors:
Group One Trading LLC
Which major investors are buying Oncobiologics stock?: In the previous quarter, OTLK stock was purchased by institutional investors including:
Citadel Advisors LLC
Susquehanna International Group LLP
In the previous year, these company insiders have bought Oncobiologics stock:
Lawrence A Kenyon (CFO)
Yezan Munther Haddadin (Director)
Learn More investors buying Oncobiologics stock.